1. Serine peptidase inhibitor Kunitz type 2 (SPINT2) in cancer development and progression
   Fernanda Marconi Roversi et al, 2018, Biomedicine & Pharmacotherapy CrossRef
2. SPINT2 is involved in the proliferation, migration and phenotypic switching of aortic smooth muscle cells: Implications for the pathogenesis of thoracic aortic dissection
   Jun Li et al, 2023, Experimental and Therapeutic Medicine CrossRef
3. Hepatocyte growth factor activator inhibitor type-1 in cancer: Advances and perspectives (Review)
   QIAOLI ZHENG et al, 2014, Molecular Medicine Reports CrossRef
4. Emerging Therapeutic Targets for Soft Tissue Sarcoma
   Jason L. Smith et al, 2011, Current Oncology Reports CrossRef
5. Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1)
   Marybeth Sechler et al, 2015, Journal of Biological Chemistry CrossRef
6. The Importance of Being Dead: Cell Death Mechanisms Assessment in Anti-Sarcoma Therapy
   Santiago Rello-Varona et al, 2015, Frontiers in Oncology CrossRef
7. Melatonin suppression of aerobic glycolysis (Warburg effect), survival signalling and metastasis in human leiomyosarcoma
   Lulu Mao et al, 2016, Journal of Pineal Research CrossRef
8. New insights into antimetastatic signaling pathways of melatonin in skeletomuscular sarcoma of childhood and adolescence
   Ko-Hsiu Lu et al, 2020, Cancer and Metastasis Reviews CrossRef